DOBUTAMINE HYDROCHLORIDE Drug Patent Profile

Which patents cover Dobutamine Hydrochloride, and what generic alternatives are available?

Dobutamine Hydrochloride is a drug marketed by Baxter Hlthcare, Dr Reddys, Hainan Poly, Hikma, Hospira, Luitpold, Teligent, Teva Parenteral, Watson Labs, and Watson Labs Inc. and is included in fifteen NDAs.

The generic ingredient in DOBUTAMINE HYDROCHLORIDE is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Dobutamine Hydrochloride

A generic version of DOBUTAMINE HYDROCHLORIDE was approved as dobutamine hydrochloride by HOSPIRA on November 29^th, 1993.

Summary for DOBUTAMINE HYDROCHLORIDE

US Patents:	0
Applicants:	10
NDAs:	15
Finished Product Suppliers / Packagers:	5
Raw Ingredient (Bulk) Api Vendors:	102
Clinical Trials:	115
Patent Applications:	740
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in DOBUTAMINE HYDROCHLORIDE?	DOBUTAMINE HYDROCHLORIDE excipients list
DailyMed Link:	DOBUTAMINE HYDROCHLORIDE at DailyMed

Recent Clinical Trials for DOBUTAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Wuhan Union Hospital, China	Phase 2/Phase 3
Ain Shams University	Phase 2/Phase 3
University of Chicago	Early Phase 1

See all DOBUTAMINE HYDROCHLORIDE clinical trials

Pharmacology for DOBUTAMINE HYDROCHLORIDE

Drug Class	beta-Adrenergic Agonist
Mechanism of Action	Adrenergic beta-Agonists

Medical Subject Heading (MeSH) Categories for DOBUTAMINE HYDROCHLORIDE

Adrenergic beta-1 Receptor Agonists

Cardiotonic Agents

Sympathomimetics

Anatomical Therapeutic Chemical (ATC) Classes for DOBUTAMINE HYDROCHLORIDE

C01CA	Adrenergic and dopaminergic agents
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01	CARDIAC THERAPY
C	Cardiovascular system

US Patents and Regulatory Information for DOBUTAMINE HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	DOBUTAMINE HYDROCHLORIDE	dobutamine hydrochloride	INJECTABLE;INJECTION	074381-001	Sep 26, 1996		DISCN	No	No
Baxter Hlthcare	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	dobutamine hydrochloride	INJECTABLE;INJECTION	020255-004	Oct 19, 1993	AP	RX	Yes	Yes
Hospira	DOBUTAMINE HYDROCHLORIDE	dobutamine hydrochloride	INJECTABLE;INJECTION	074292-001	Feb 16, 1995		DISCN	No	No
Hikma	DOBUTAMINE HYDROCHLORIDE	dobutamine hydrochloride	INJECTABLE;INJECTION	074277-001	Oct 31, 1994	AP	RX	No	No
Watson Labs Inc	DOBUTAMINE HYDROCHLORIDE	dobutamine hydrochloride	INJECTABLE;INJECTION	074279-001	Feb 18, 1998		DISCN	No	No
Hospira	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	dobutamine hydrochloride	INJECTABLE;INJECTION	020201-003	Oct 19, 1993	AP	RX	Yes	Yes